NCS Multistage acquires tracer diagnostics provider ResMetrics

Published 01/08/2025, 11:46
NCS Multistage acquires tracer diagnostics provider ResMetrics

HOUSTON - NCS Multistage Holdings, Inc. (NASDAQ:NCSM), a $78 million market cap energy services company whose stock has surged over 71% in the past year, has acquired ResMetrics LLC, a provider of chemical tracer diagnostics services for the oil and gas industry, the company announced Thursday.

The acquisition aims to complement and strengthen NCS’s existing tracer diagnostics capabilities. ResMetrics specializes in chemical tracer technologies that help operators validate reservoir development strategies, improve fracture stimulation designs, evaluate well connectivity, and optimize enhanced oil recovery programs. According to InvestingPro analysis, NCS maintains a strong financial position with more cash than debt and a healthy current ratio of 4.57, suggesting ample resources for strategic acquisitions.

"ResMetrics brings trusted chemical tracer technologies that complement our existing capabilities, enhancing our ability to deliver actionable insights that help customers maximize well performance and financial returns," said Ryan Hummer, NCS’s Chief Executive Officer. The company’s financial performance supports this strategic move, with InvestingPro data showing 18.16% revenue growth and an overall financial health score rated as "GREAT". Additional insights and detailed analysis are available in InvestingPro’s comprehensive research report, one of 1,400+ deep-dive reports available to subscribers.

Sharad Behal, Chief Executive Officer of ResMetrics, stated that joining NCS is expected to accelerate the company’s growth and increase the range of diagnostics solutions available to customers. Based on InvestingPro’s Fair Value analysis, NCS currently appears undervalued, suggesting potential upside for investors as the company executes its growth strategy.

ResMetrics was developed in partnership with CSL Capital Management. Shook, Hardy and Bacon L.L.P. served as legal advisor to NCS, while Piper Sandler acted as exclusive financial advisor and Winston Strawn LLP served as legal advisor to ResMetrics.

NCS plans to provide additional details about the acquisition during its second quarter earnings conference call scheduled for August 1, 2025.

ResMetrics primarily operates in the United States, the UAE, and Kuwait, providing services that help customers assess and improve completion designs and optimize reservoir development and production.

The financial terms of the transaction were not disclosed in the press release statement.

In other recent news, NCS Multistage Holdings Inc reported impressive financial results for the first quarter of 2025. The company announced earnings per share of $1.51, significantly surpassing the forecasted $0.89. Additionally, NCS Multistage’s revenue reached $50 million, exceeding expectations of $45.71 million. These results highlight a strong start to the year for the company. In other developments, NCS Multistage held its 2025 Annual Meeting of Stockholders, where two Class II Directors, Robert Nipper and Ryan Hummer, were elected. The meeting also saw the ratification of the company’s independent accounting firm and the advisory approval of executive compensation. Furthermore, the Amended and Restated 2017 Equity Incentive Plan received approval. These recent developments reflect key activities and strategic decisions at NCS Multistage Holdings Inc.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.